Branched-chain amino acid aminotransferase (BCAT) catalyzes bidirectional transamination in the cell between branched-chain amino acids (BCAAs; valine, leucine, and isoleucine) and branched-chain α-keto acids (BCKAs; α-ketoisovalerate, α-ketoisocaproate, and α-keto-β-methylvalerate). Eukaryotic cells contain two types of paralogous BCATs: mitochondrial BCAT (BCATm) and cytosolic BCAT (BCATc). Both isozymes have identical enzymatic functions, so they have long been considered to perform similar physiological functions in the cells. However, many studies have gradually revealed the differences in physiological functions and regulatory mechanisms between them. In this article, we present overviews of BCATm and BCATc in both yeast and human. We also introduce BCAT variants found natively or constructed artificially, which could have significant implications for research into the relationship between the primary structures and protein functions of BCATs. KEY POINTS: • BCAT catalyzes bidirectional transamination in the cell between BCAAs and BCKAs. • BCATm and BCATc are different in the metabolic roles and regulatory mechanisms. • BCAT variants offer insight into a relationship between the structure and function.

• PMID: 34622336
• DOI full text
• PubMed
• PubTator

Reference Type

Journal Article | Review

Authors

Toyokawa Y, Koonthongkaew J, Takagi H

Primary Lit For

Additional Lit For

Review For

PUT3 | GCN4 | IXR1 | COX20 | BAT1 | GLN3 | BAT2 | ABD1 | ATM1 | TAZ1 | ACO1 | ... Show allLEU3 | ALD2 | ACE2 | TORC1 serine/threonine-protein kinase complex, TOR1 variant | TORC1 serine/threonine-protein kinase complex, TOR2 variant Show fewer